|
Index of reports
> Cases resulting in life threatening events (24)
> Cases with Palmar-Plantar Erythrodysaesthesia Syndrome (8)
Below is the selection of adverse event reports related to Nexavar (Sorafenib) that includes cases resulting in life threatening events where reactions include palmar-plantar erythrodysaesthesia syndrome.
Adverse event in 70 year old female receiving Nexavar (Sorafenib)
Reported by a individual with unspecified qualification from United States on 2007-04-11
Patient: 70 year old female
Adverse reactions / side effects: Weight Decreased, Pruritus, Wheelchair User, Constipation, Erythema, Skin Lesion, Decreased Appetite, Blister, Stomatitis, Angioedema, Cataract, Haematuria, Palmar-Plantar Erythrodysaesthesia Syndrome, DRY Skin, Dysgeusia, Dysphonia, Dysuria, Alopecia, Vision Blurred, Hypertension
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Nexavar
Dosage: total daily dose: 800 mg unit dose: 200 mg
Administration route: Oral
Indication: Metastatic Renal Cell Carcinoma
Start date: 2006-04-16
End date: 2006-05-03
Nexavar
Dosage: total daily dose: 400 mg unit dose: 200 mg
Administration route: Oral
Start date: 2006-05-03
End date: 2006-06-26
Nexavar
Administration route: Oral
Nexavar
Dosage: total daily dose: 200 mg unit dose: 200 mg
Administration route: Oral
Start date: 2006-07-16
End date: 2006-12-10
Other drugs received by patient: Pindolol; Protonix; Thalidomide Therapy
Adverse event in 75 year old male receiving Nexavar (Sorafenib)
Reported by a physician from Japan on 2007-04-10
Patient: 75 year old male, weighing 67.0 kg (147.4 pounds)
Adverse reactions / side effects: Neuropathy Peripheral, Palmar-Plantar Erythrodysaesthesia Syndrome, Melaena, Cardiac Arrest, Epistaxis
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Nexavar (Sorafenib)
Other drugs received by patient: Stomilase; Harnal D; Humalog; Lantus
Adverse event in 75 year old male receiving Nexavar (Sorafenib)
Reported by a physician from Japan on 2007-04-09
Patient: 75 year old male, weighing 67.0 kg (147.4 pounds)
Adverse reactions / side effects: Neuropathy Peripheral, Palmar-Plantar Erythrodysaesthesia Syndrome, Melaena, Cardiac Arrest, Epistaxis
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Nexavar (Sorafenib)
Other drugs received by patient: Stomilase; Harnal D; Humalog; Lantus
Adverse event in 75 year old male receiving Nexavar (Sorafenib)
Reported by a physician from Japan on 2007-03-28
Patient: 75 year old male, weighing 67.0 kg (147.4 pounds)
Adverse reactions / side effects: Neuropathy Peripheral, Palmar-Plantar Erythrodysaesthesia Syndrome, Melaena, Cardiac Arrest, Epistaxis
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Nexavar (Sorafenib)
Other drugs received by patient: Stomilase; Harnal D; Humalog; Lantus
Adverse event in 75 year old male receiving Nexavar (Sorafenib)
Reported by a physician from Japan on 2007-03-23
Patient: 75 year old male, weighing 67.0 kg (147.4 pounds)
Adverse reactions / side effects: Neuropathy Peripheral, Palmar-Plantar Erythrodysaesthesia Syndrome, Melaena, Cardiac Arrest, Epistaxis
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Nexavar (Sorafenib)
Other drugs received by patient: Stomilase; Harnal D; Humalog; Lantus
Adverse event in 75 year old male receiving Nexavar (Sorafenib)
Reported by a physician from Japan on 2007-03-21
Patient: 75 year old male, weighing 67.0 kg (147.4 pounds)
Adverse reactions / side effects: Neuropathy Peripheral, Palmar-Plantar Erythrodysaesthesia Syndrome, Melaena, Cardiac Arrest, Epistaxis
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Nexavar (Sorafenib)
Other drugs received by patient: Stomilase; Harnal D; Humalog; Lantus
Adverse event in 70 year old female receiving Nexavar (Sorafenib)
Reported by a individual with unspecified qualification from United States on 2007-03-14
Patient: 70 year old female
Adverse reactions / side effects: Weight Decreased, Pruritus, Stomatitis, Wheelchair User, Palmar-Plantar Erythrodysaesthesia Syndrome, Constipation, Erythema, Dysgeusia, Dysphonia, Dysuria, Alopecia, Skin Lesion, Hypertension, Decreased Appetite, Blister
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Nexavar
Dosage: total daily dose: 400 mg unit dose: 200 mg
Administration route: Oral
Indication: Renal Cell Carcinoma Stage Unspecified
Start date: 2006-06-26
End date: 2006-07-12
Nexavar
Dosage: total daily dose: 200 mg unit dose: 200 mg
Administration route: Oral
Start date: 2006-07-16
Nexavar
Dosage: total daily dose: 400 mg unit dose: 200 mg
Administration route: Oral
Nexavar
Dosage: total daily dose: 800 mg unit dose: 200 mg
Administration route: Oral
Start date: 2006-04-16
End date: 2006-06-17
Other drugs received by patient: Pindolol; Protonix; Thalidomide Therapy
Adverse event in 75 year old male receiving Nexavar (Sorafenib)
Reported by a physician from Japan on 2007-03-06
Patient: 75 year old male
Adverse reactions / side effects: Palmar-Plantar Erythrodysaesthesia Syndrome, Depressed Level of Consciousness, Hypoaesthesia, Cardiac Arrest
Adverse event resulted in: life threatening event
Suspect drug(s):
Nexavar (Sorafenib)
|
